Program 2018-01-23T11:42:47+00:00

Scientific Program

For your convenience, you can download a PDF ready-for-print version of the program here.

Sunday, May 27, 2018
19:00 Welcome Reception
Monday, May 28, 2018
08:30-10:30 Session 1A: Fertility Preservation 08:30-10:30 Session 1B: Preimplantation Genetic Diagnosis (PGD)
Chair: Lee Shulman, USA
08:30-08:50 Ovarian transplantation: Single center results and world registry
Dror Meirow, Israel
08:30-09:00 Basic Genetic Principles for the Non-Genetics Yuval Yaron, Israel
08:50-09:15 Use of dried sperm in large mammals’ assisted reproduction
Joseph Saragusty, Italy
09:00-09:30 From Expanded Carrier screening to PGD
Nathan Treff, USA
09:15-09:40 Fully Automated Vitrification System
Amir Arav, Israel
09:30-10:00 PGD from theory to practice
Talia Eldar Geva, Israel
09:40-10:05 Frontiers in fertility preservation – merging biology and technology
Francesca Duncan, USA
10:00-10:30 Cancer genes and fertility treatment: where oncofertility and PGD intersect
Avner Hershlag, USA
10:05-10:30 Creation of artificial Testis: The state of the art
Yoni Baert, Belgium
10:30-11:00 Coffee Break
 11:00-13:15 Session 2: Opening Session – Reproductive Medicine, IVF and Genetics: Past Present and Future
11:00-11:05 Welcome
11:05-11:20 The Really First Step
Simon Fishel, UK
11:20-11:45 Past, Present and Future of IVF
Alan DeCherney, USA
11:45-12:15 The first IVF child in Israel – The fifth in the world
Shlomo Mashiach, Israel & Jehoshua Dor, Israel
12:15-12:30 Introduction to IVF – State of Israel
Joseph Schenker, Israel
12:30-12:45 On the shoulders of giants: How Israel became the “IVF nation”
Neri Laufer, Israel
12:45-13:15 Self-Organization and Symmetry Breaking Through Partnership Between Embryonic and Extra-Embryonic Tissues
Magdalena Zernicka-Goetz, UK
13:15-14:00 Lunch Break
14:00-16:00 Session 3A: Recombinant vs. Biosimilar Gonadotropin 14:00-16:05 Session 3B: Preimplantation Genetic Screening (PGS)
Recombinant vs. biosimilar gonadotropin
Recombinant: Manuela Simoni, Italy
Biosimilar: TBA
Recombinant plus AMH: TBA
14:00-14:25 Should PGS be implemented to routine IVF practice?
Raoul Orvieto, Israel
14:25-14:50 Non-inherited chromosomal and genomic abnormalities in human embryos and how to prevent them
Santiago Munne, USA
 15:30-16:00 Breast cancer: Non gonadal effects of Gonadotropins
Andrea Genazzani, Italy
14:50-15:15 PGT-A – state of the ART: Contemporary management of mosaic range results
Richard Scott, USA
15:15-15:40 What Causes Genomic Instability During Preimplantation Embryo Development?
David Keefe, USA
15:40-16:05 Genomics in women’s health that would encompass prenatal, cancer, adult disease
Lee Shulman, USA
16:00-16:30 Coffee Break
16:30-18:00 Session 4A: Stem Cells; the CEO of Our Body 16:30-18:00 Session 4B: Optimizing Egg Yield for IVF
16:30-17:00 Human embryonic stem cells – from the IVF tube to clinical transplantation
Benjamin Reubinoff, Israel
 16:30-17:00 Errors in IVF- Lessons from Aviation
Michael Alper, USA
 17:00-17:30 Making human oocytes from stem cells
Evelyn Telfer, UK
 17:00-17:30 Optimizing results in poor responder patients Norbert Gleicher, USA
 17:30-18:00 Can we stop ovarian aging?
Helen Picton, UK
17:30-18:00 Improving IVF: Is there a limit to our ability to manipulate human biology
Pasquale Patrizio, USA
Tuesday, May 29, 2018
09:00-11:00 Session 5A: Reproductive Surgery 09:00-11:00 Session 5B: Recent Development in Genomic Science and ART
 09:00-09:30 Advanced laparoscopy for endometriosis associated infertility
Carman Nezhat, USA
 09:00-09:30 Optimizing CRISPR/Cas9 genome engineering efficiencies in the mouse zygote
Ben Davies, UK
09:30-10:00 Optimizing uterine fibroid management in the infertile patient
09:30-10:00 Primordial follicle recruitment and ovarian reserve
Sherman Silber, USA
10:00-10:30 Hysteroscopy and infertility: state of the art
Attilio Di Spiezio Sardo, Italy
10:00-10:30 Endometriosis, Adenomyosis and IVF
   10:30-11:00 Laparoscopic and hysteroscopic cesarean niche resection
Motti Goldenberg, Israel
   10:30-11:00 ART Pregnancies: Are they Different?
Jaideep Malhotra, India
11:00-11:30 Coffee Break
11:30-13:15 Session 6A: Uterus Transplantation 11:30-13:00 Session 6B: Support the Luteal Phase and Implantation
11:30-11:55 11:55-12:20 Uterine transplantation:
From vision to healthy Babies: Pernilla Dahm-Kähler, Sweden
Uterus Transplantation- lessons learned: Tommaso Falcone, USA
 11:30-12:00 Searching for the optimal vehicle and dose of progesterone to support the luteal phase in ART
12:20-12:45 Uterine Transplant: Can the Promise be Fulfilled?
Robert Stillman, USA
 12:00-12:30 Mini hCG for luteal phase support: a more physiologic LPS for ART
Robert Fischer, Germany
12:30-13:00 PIF monotherapy in allotransplant with return to function
Eytan Barnea, USA
12:45-13:15 SARG In 2058 Ce:  Anticipating The Next Forty Years Of IVF Innovations
Gerald Schatten, USA
13:15-14:00 Lunch Break
14:00-15:30 Session 7A: Male Infertility 14:00-15:30 Session 7B: Into the Future: The British Session
 14:00-14:30 Where are we and where should and will we go in evaluating male reproductive potential: The now and future of treating the azoospermic male
Craig Niederberger, USA
14:00-14:25 Where does PCOS come from?
Roy Homburg, Israel
 14:25-14:50 The next 40 years….the ART of the possible
Gillian Lockwood, UK
 14:30-15:00 The use of microfluidic sperm sorting chip may increase pregnancy rate
Bulent Tiras, Turkey
14:50-15:10 15:10-15:30 Debate: Global Freezing:
For: Charles Kingsland, UK
Against: Tony Rutherford, UK
15:00-15:30 Sperm testing Advances: “One Small Step for Man (to Collect at Home). One Giant Leap for Mankind”
Ben Leader, USA
15:30-16:00 Coffee Break
16:00-17:30 Session 8: Embryo Selection: Invasive vs. None-Invasive Technique
 16:00-16:25 Maximizing successful implantation: TLI, PGS and AnxaV M2 haptlotype
Simon Fishel, UK
16:25-16:50 Third party reproductive medicine
Tomer Singer, USA
 16:50-17:15 Color Doppler n3D-4D in human reproduction
Narendra Malhotra, India
17:15-17:30  Closing remarks